Clinical trial
Administration of PCC in Patients Admitted in Emergency Care Units for Severe Bleeding While Receiving Oral Anticoagulants: Impact of an Expert ECRF on Adherence to Rules of Proper Use and Outcome
NCT03320603 is registered in ClinicalTrials.gov with Octapharma as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Administration of PCC in Patients Admitted in Emergency Care Units for Severe Bleeding While Receiving Oral Anticoagulants: Impact of an Expert ECRF on Adherence to Rules of Proper Use and Outcome
- Lead sponsor
- Octapharma
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 13, 2017
- Completion date
- December 20, 2020
- Enrollment
- 397 (actual)
- Sites
- 26
Conditions
As the registry lists them; a condition with its own page is linked.
emergency care for severe bleeding while on anticoagulants